Aims There are few studies of the use of intra-aortic balloon pump (IABP) treatment as a bridge to heart transplantation (HTx). This is the first study to compare long-term clinical and haemodynamic ...
Despite a lack of evidence, circulatory support with intraaortic balloon counterpulation (IABP) has a class 1 recommendation in the guidelines and is often used in patients in cardiogenic shock ...
MUNICH and WAYNE, N.J., Aug. 27, 2012 /PRNewswire/ -- MAQUET Cardiovascular LLC, the market leader in intra-aortic balloon counterpulsation therapy, today announced 30-day results from the large, ...
Intra-aortic balloon pump (IABP) therapy fails to reduce infarct size or improve clinical outcomes when added prior to primary percutaneous coronary intervention (PCI) in patients with high-risk ...
Intra-aortic balloon pump counterpulsation prior to PCI in patients with ST segment elevation MI does not reduce infarct size as measured by MRI, according to results from the Counterpulsation Reduces ...
Please provide your email address to receive an email when new articles are posted on . Infarct size as measured by MRI does not reduce when intra-aortic balloon pump counterpulsation is used before ...
The results of the Intraaortic Balloon Pump in Cardiogenic Shock (IABP-SHOCK) II trial, presented at the 2012 European Society of Cardiology Congress and published in the New England Journal of ...
Routine use of intra-aortic balloon counterpulsation (IABC) in STEMI patients who do not have cardiogenic shock does not reduce infarct size, according to a new trial. Results from the CRISP AMI ...
MUNICH, Germany—Although use of an intra-aortic balloon pump (IABP) in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock appears safe, the technique does not improve ...
DUBLIN--(BUSINESS WIRE)--The "US Market Report for Intra-Aortic Balloon Pumps 2018 - MedCore" report has been added to Research and Markets' offering. An intra-aortic balloon pump system is used for ...
This study demonstrates that IABP is a valuable tool as a bridge to HTx in patients with end-stage heart failure. Kaplan–Meier analysis revealed no significant difference in post-HTx survival between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results